The autonomous growth of human papillomavirus type 16-immortalized keratinocytes is related to the endothelin-1 autocrine loop

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 6898-6904

  Venuti, Aldo ^a,b   Marcante, Maria Luisa ^a   Flamini, Silvio ^a   Di Castro, Valeriana ^b   Bagnato, Anna ^b  

^a Laboratory of Molecular Virology and Oncology   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR;

ARTICLE; CELL GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION; WART VIRUS;

EID: 0030749212     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.6898-6904.1997     Document Type: Article

References (50)

1. Adachi, M., Y.-Y. Yang, Y. Furuichi, and C. Miyamato. 1991. Cloning and characterization of cDNA encoding human A-type endothelin receptor. Biochem. Biophys. Res. Commun. 180:1265-1272.
2. Agarwal, C., E. A. Rorke, J. C. Irwin, and R. L. Eckert. 1991. Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation. Cancer Res. 51:3982-3989.
3. Aral, H., S. Hori, I. Aramori, H. Ohkuho, and S. Nakanishi. 1990. Cloning expression of a cDNA encoding an endothelin receptor. Nature (London) 348:730-732.
4. A receptor subtype that mediates endothelin induced autocrine proliferation of normal human keratinocytes. Biocnem. Biophys. Res. Commun. 209:8-86.
5. Bagnato, A., R. Tecce, C. Moretti, V. Di Castro, D. Spergel, and K. J. Catt. 1995. Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells. Clin. Cancer Res. 1:1059-1066.
6. Bagnato, A., R. Tecce, V. Di Castro, and K. J. Catt. 1997. Activation of mitogenic signaling by endothelin-1 in ovarian carcinoma cells. Cancer Res. 57:1306-1311.
7. Baley, P. A., T. J. Resink, U. Eppenberger, and A. W. A. Hahn. 1990. Endothelin messenger RNA and receptors are differentially expressed in cultured human breast epithelial and stromal cells. J. Clin. Invest. 85:1320-1323.
8. Banks, L., and G. Matlashewski. 1993. Cell transformation and HPV E5 gene. Papillomavirus Rep. 4:1-3.
9. Battistini, B., P. Chailler, P. D'orléans-Juste, N. Brière, and P. Sirois. 1993. Growth regulatory properties of endothelins. Peptides 14:385-399.
10. Coffey, R. J., Jr., R. Derynck, J. R. Wilcox, T. S. Bringmun, A. S. Goustin, H. L. Moses, H. L., and M. R. Pittelkow. 1987. Production and auto-induction of transforming growth factor in human keratinocytes. Nature (London) 328:817-820.
11. Di Marco, E., P. C. Marchisio, S. Bondanza, A. T. Franzi, R. Cancedda, and M. De Luca. 1991. Nerve growth factor hinds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J. Biol. Chem. 266:21718-21722.
12. Dyson, N., P. M. Howley, K. Munger, and E. Harlow. 1989. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblasloma gene product. Science 243:934-937.
13. A antagonist (BQ 123) inhibits endothelin-1 induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells. FEES Lett. 302:243-246.
14. Ekstrand, A. J., C. D. James, W. K. Cavence, B. Selinger, R. F. Pettersson, and V. P. Collins. 1991. Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 51:2164-2172.
15. Franco, E. L. 1995. Cancer causes revisited: human papillomavirus and cervical neoplasia. J. Natl. Cancer Inst. 87:779-780.
16. Halaban, R., R. Langdon, N. Birchall, C. Cuono, A. Baird, G. Scott, G. Moellmann, and J. McGuire, 1988. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J. Cell. Biol. 107:1611-1619.
17. Hosoda, K., K. Nakao, N. Tamura, H. Arai, Y. Ogawa, S. Suga, S. Nakanishi, and H. Imura. 1992. Organization, structure, chromosomal assignment and expression of the gene encoding the human endothelin-1 receptor. J. Biol. Chem. 267:18797-18804.
18. Iglesias, M., G. D. Plowman, and D. Woodworth. 1995. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro. Am. J. Pathol. 146:944-952.
19. Imokawa, G., Y. Yada, and M. Miyagishi. 1992. Endothelins secreted from keratinocytes are intrinsic mitogens for human melanocytes. J. Biol. Chem. 267:24675-24680.
20. Ishikawa, K., T. Fukami, T. Nagase, T. Mase, T. Hayama, K. Niiyama, K. Fujita, Y. Urakawa, U. Kumagai, T. Fukuroda, M. Ihara, and M. Yano. 1992. In C. H. Schneider and A. N. Eberle (ed.), Peptides, p. 685-686. ESCOM Science, Leiden, The Netherlands.
21. Ishikawa, K., M. Ihara, K. Noguchi, T. Mase, N. Mino, T. Saeki, T. Fukuroda, T. Fukami, S. Ozaki, T. Nagase, M. Nishikibe, and M. Yano. 1994. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ 788. Proc. Natl. Acad, Sci. USA 91:4892-4896.
22. Kusuhara, M., K, Yamaguchi, K. Nagasaki, C. Hayashi, A. Suzaki, S. Hori, S. Handa, Y. Nakamura, and K. Abe. 1990. Production of endothelin in human cancer cell lines. Cancer Res. 50:3257-3261.
23. Lang, R. A., and A. W. Burgess. 1990. Autocrine growth factors and tumorigenic transformation. Immunol. Today 11:244-249.
24. Nelson, J. B., K. Chan-Tack, S. P. Hedican, J. J. Opgenorth, G. S. Bova, and J. W. Simons. 1996. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res. 56:663-668.
25. Pimm, D., M. Collins, and L. Banks. 1992. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7:27-32.
26. Pirisi, L., S. Yasumoto, M. Feller, J. Doniger, and J. A. Di Paolo. 1987. Transformation of human fibroblasts and keratinocytes with human papillomavirus Type 16 DNA. J. Virol. 61:1061-1066.
27. Rieckmann, P., M. Albrecht, H. Ehrenreich, T. Weber, and U. Michel. 1995. Semi-quantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction. Res. Exp. Med. 195:17-29.
28. Ro, J., S. M. North, G. E. Gallik, G. N. Hortobagyi, J. U. Gutterman, and M. Blick. 1988. Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res. 48:161-164.
29. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. 1990. Cloning of a cDNA encoding a non-isopeptide-selec tive subtype of the endothelin receptor. Nature (London) 348:732-735.
30. Sakurai, T., M. Yanagisawa, and T. Masaki. 1992. Molecular characterization of endothelin receptors. Trends Pharmacol. Sci. 13:103-107.
31. Schlegel, R.,W.C. Phelps, Y. L. Zhang, and M. Borbosa. 1988. Quantitative keratinocytes assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J. 7:3181-3187.
32. Schrey, M. P., K. V. Patel, and N. Tezapsidis. 1992. Bombesin and glucocorticoids stimulate human breast cancer cells to produce endothelin, a paracrine mitogen for breast stroml cells. Cancer Res. 52:1786-1790.
33. Schwarz, E., U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (London) 314: 111-114.
34. Shichiri, M., Y. Hirata, T. Nakajima, K. Andok, T. Imai, M. Yanagisawa, T. Masaki, and F. Marumo. 1991. Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. J. Clin. Invest. 87:1867-1871.
35. Sizemore, N., and E. A. Rorke. 1993. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression. Cancer Res. 53:4511-4517.
36. Straight, S. W., P. M. Hinkle, R. J. Jewers, and D. J. McCance. 1993. The E5 oncoprotein in human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67:4521-4532.
37. Stojilkovic, S. S., F. Merelli, T. Iida, L. Z. Krsmanovic, and K. J. Catt. 1990. Endothelin stimulation of cytosolic calcium and gonadotropin secretion in anterior pituitary cells. Science 248:1663-1666.
38. 37a. Venuti, A. Personal communication.
39. Werness, B. A., A. J. Levine, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
40. Williams, D. L., K. L. Jones, D. J. Pettibone, E. V. Lis, and B. V. Clineshmidt. 1991. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res. Commun. 175:556-561.
41. Wong, A. J., S. H. Bigner, D. D. Bigner, K. W. Kinzler, S. R. Hamilton, and B. Volgestein. 1987. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. USA 84:6899-6903.
42. Woodworth, C. D., E. McCullin, M. Iglesias, and G. D. Plowman. 1995. Interleukin 1α and tumor necrosis factor α stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc. Natl. Acad. Sci. USA 92:2840-2844.
43. Yada, Y., K. Higuchi, and G. Imokawa. 1991. Effects of endothelins on signal transduction and proliferative in human melanocytes. J. Biol. Chem. 266: 18352-18357.
44. Yamashita, J., M. Ogawa, H. Egami, S. Matsuo, H. Kiyohara, K. Inada, S. Yamashita, and S. Fujita. 1992. Abundant expression of immunoreactive endothelin-1 in mammary phyllodes tumor: possible paracrine role of endothelin-1 in the growth of stromal cells in phyllodes tumor. Cancer Res. 52:4046-4049.
45. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1989. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London) 332:411-415.
46. Yohn, J. J., J. G. Morelli, S. J. Walchak, K. B. Rundell, D. A. Norris, and M. R. Zamora. 1993. Cultured human keratinocytes synthesize and secrete endothelin-1. J. Invest. Dermatol. 100:23-26.
47. Zhengming, G., and G. Matlashewski. 1995. Effect on human papillomavirus type 16 oncogenes on mitogen-activated protein kinase activity. J. Virol. 69:8051-8056.
48. zur Hausen, H. 1994. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 343:955-957.
49. zur Hausen, H. 1990. Roots and perspectives of contemporary papillomavirus research. J. Cancer Res. Clin. Oncol. 122:3-13.
50. Zyzak, L. L., L. M. MacDonald, A. Batova, R. Forand, K. E. Creek, and L. Pirisi. 1994. Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes. Cell Growth Differ. 5:537-547.